2019
DOI: 10.21037/jtd.2019.06.34
|View full text |Cite
|
Sign up to set email alerts
|

Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…Esophageal pressure guided PEEP titration has been evaluated in two trials [447,448]. While the pilot study suggested benefit [448], the subsequent 200 patient multicentre RCT that compared PEEP titration guided by esophageal (P ES ) measurement versus empirical high PEEP-FiO 2 titration, showed no significant difference in a composite outcome of death and days free from mechanical ventilation through day 28 [449]. There are limited data on ventilation strategies for patients with sepsis-induced respiratory failure who do not meet criteria for ARDS.…”
Section: Rationalementioning
confidence: 99%
“…Esophageal pressure guided PEEP titration has been evaluated in two trials [447,448]. While the pilot study suggested benefit [448], the subsequent 200 patient multicentre RCT that compared PEEP titration guided by esophageal (P ES ) measurement versus empirical high PEEP-FiO 2 titration, showed no significant difference in a composite outcome of death and days free from mechanical ventilation through day 28 [449]. There are limited data on ventilation strategies for patients with sepsis-induced respiratory failure who do not meet criteria for ARDS.…”
Section: Rationalementioning
confidence: 99%
“…Esophageal pressure guided PEEP titration has been evaluated in two trials (447, 448). While the pilot study suggested benefit (448), the subsequent 200 patient multicenter RCT that compared PEEP titration guided by esophageal (P ES ) measurement versus empirical high PEEP-FiO 2 titration, showed no significant difference in a composite outcome of death and days free from mechanical ventilation through day 28 (449).…”
Section: Screening and Early Treatmentmentioning
confidence: 99%
“…The larger multicentre EPVent-2 trial (n=200, composite primary end-point incorporating mortality and ventilator-free days at day 28) did not find clinical benefits of targeting positive end-expiratory P L of 0-6 cmH 2 O compared with empirical high PEEP (high PEEP-F IO 2 table) [43]. The fact that PEEP and P plat between groups were similar during the first week and higher compared with other ARDS trials [44], and that P oes -guided PEEP setting resulted in rather high end-expiratory P L , could have contributed to the discrepancy with EPVent-1 results. Recent post-hoc reanalysis of EPVent-2 suggested better survival with P oes -guided PEEP in patients having lower Acute Physiology and Chronic Health Evaluation (APACHE) II score (less severe multiple organ failure) and that benefits could be maximised by targeting end-expiratory P L tightly within 0±2 cmH 2 O compared with higher or more negative values [45].…”
Section: Artefactsmentioning
confidence: 91%